Carinna Hockham is a postdoctoral Research Associate in the Global Women’s Health Program at The George Institute for Global Health, Imperial College London.

She has an MSc in Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine and a DPhil in Epidemiology from the University of Oxford. Her current research primarily involves the use of large population databases, together with linked routinely-collected health data, to examine sex- and gender-based differences in risk factors for chronic kidney disease and multimorbidity, as well as associated health outcomes and health service use. In addition, Carinna has worked on multiple randomised controlled trials involving novel adaptive methodology (e.g. BEAT-Calci and CLARITY) and was an inaugural Fellow of the Innovative Trials Development Group at the Institute. 

Vikash R Keshri is Senior Research Fellow at the George Institute for Global Health. He has completed MBBS and MD in community medicine from the Mahatma Gandhi Institute of Medical Sciences (MGIMS), Wardha in India, and a short course in Health Policy Analysis from Institute of Tropical Medicine, Antwerp, Belgium.

Vikash has around 10 years of experience in public health and health systems besides a couple of years as a clinician. Prior to joining TGI, has worked extensively in various capacity in varied organizations, such as missionary hospital, Department of Community Medicine at MGIMS, FHI 360 for MP health sector reform project, State Resource Unit and Care INDIA in Bihar, the Centre for Health Policy at Asian Development Research Institute, Patna. He has experience of working closely with policymakers and health systems stakeholders in many states in India.

His professional and research interest revolve around health systems and policy research (HPSR), especially policy analysis, governance, human resource for health and organization of health services in resource-constrained settings.  At TGI, he is working on improving recovery outcome of Burns survivors with a systems approach applying the HPSR lens.

Allison has been working in clinical research since 1992 and managing clinical trials since 2001, working in the fields of hypertension, preeclampsia, HIV, obesity and respiratory medicine. Allison has worked in hospital settings (St George Hospital, Sydney; Leicester Royal Infirmary, UK; Groote Schuur Hospital, RSA) and University/Medical Research Institutes (Kirby and The George Institute).

Since working at The George Institute, she has worked as a Senior Project Manager and Operational Lead in APO and now holds an academic position in the Respiratory Programme. Allison has managed project teams to deliver multiple clinical trials and research projects such as TASCS, ECOS, PACE in COPD and now the BREATHE CDSS.

Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.

Dr Anna Campain is a biostatistician with experience in health, medical and bioinformatics research.

She has worked extensively with routinely-collected health data, both linked and non-linked. Anna has a special interest in using routinely-collected health datasets to explore and understand health patterns in high-risk or vulnerable populations to inform treatments, approaches and behaviours. She is passionate about research that will be translated to end-user benefit through changes in clinical guidelines, health policy and resource management.

Joining The George Institute for Global Health in 2018, Anna brings over a decade of experience in applied statistics. As an applied statistician, Anna is passionate about using robust, appropriate and contemporary statistical methods to investigate clinically important research questions. Her experience to date has involved the application of advanced regression methods and machine learning techniques to chronic disease research, the use of accessible data visualisation methods to disseminate findings to a wide research audience, and regional, state and national health program evaluation and impact investigations.

Kate has a background in Pharmacology and a PhD in the inflammatory system. She began her employment at TGI in March 2018, mainly working within the renal and metabolic division. Kate’s clinical research operations skills developed whilst working on the REDUCCTION study where she managed sites, coordinated event adjudication processes, maintained data trackers, monitored data collection, upheld ethics and research governance approvals, submitted ethics amendments, coordinated site payments, and maintained close communication with participating study sites. Her expertise has also been lent to other studies including TRIDENT (project forecasting and coordinating outcome adjudications), TRACK (unblinded team member), RESOLVE (event verification), and ATHENA (UAT). Experience has also been obtained in start-up, site initiation, site close-out, protocol and other document development, and exposure to data linkage processes.

Kate currently manages the PERFORM-AKI, ACCESS HD, DISCOVER and REVERSE studies.

Dr Katie Harris is a Senior Research Fellow in the Professorial Unit at the George Institute for Global Health. Her areas of expertise include Biostatistics and Clinical Epidemiology, awarded a PhD in Biostatistics from the University of Leeds, UK. She also holds a Conjoint Senior Lecturer position at the University of New South Wales, Sydney, Australia.

Katie has extensive experience working with big data, including population-based, linked and non-linked datasets, and clinical trials data. Her current research interests are in sex and gender differences, cardiovascular disease and hypertension, and dementia and cognitive decline.

Professor Clare Arnott is Director of the Cardiovascular Program at The George Institute for Global Health and Associate Professor in Medicine at UNSW Sydney. 

Prof Arnott’s research focuses on women’s heart disease, heart failure, cardiovascular imaging, and cardio-kidney-metabolic (CKM) disease. Her work has significantly influenced national health policy and clinical management. 

As an experienced clinical trialist and the recipient of $28 million in research funding, Prof Arnott is an expert in investigating novel cardiometabolic treatments and pregnancy-related cardiovascular diseases including pre-eclampsia and pulmonary hypertension. 

She is also Pagent Director of Heart Lung Clinical Research at St Vincent's Hospital, Sydney, Director and Founder of the Women’s Heart Clinic at Royal Prince Alfred Hospital, and Senior Staff Specialist Cardiologist at St Vincent’s Hospital and Royal Prince Alfred Hospital, Sydney.

Prof Arnott is a Fellow of the Cardiac Society of Australia and New Zealand and the European Society of Cardiology, and member of the ANZACT Steering Committee, as well as serving on the editorial board of Heart, Lung and Circulation. 

Preety R. Rajbangshi is a Senior Research Fellow at The George Institute for Global Health, India, where she leads India's Global Women's Health Programme. She holds a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health, United States.

Her research focuses on women's health across the life course and strengthening health systems for primary care. With nearly two decades of experience as a researcher and practitioner, she has worked on maternal health, anaemia, and endometriosis. She has prior experience working with government health programmes at national and state levels in India.

Preety brings extensive field experience in community engagement with tribal communities, internally displaced populations, and women workers in tea plantations. Her work aims to address health inequities and generate practice-based evidence to inform action.

Yuan LI joined TGI China in January 2017. As the head of Nutrition and lifestyle program, Yuan’s research focused on nutrition and chronic disease prevention, currently working on projects such as Action on Salt China, EduSaltS,FoodSwitch and SmartDiet.

Yuan received PhD degree of nutrition and food hygiene from the National Institute for Nutrition and Health, China CDC in 2007 and acquired the associate professor qualification identified by the China’s Ministry of Health in 2011. Yuan was offered a conjoint lecturer in the Faculty of Medicine, University of New South Wales in 2017. Yuan is an accredited Registered Dietitian in China and a committee member of Nutrition and Non-communicable Disease Control Branch at Chinese Nutrition Society.

Yanqing graduated from Hebei Northern College in 2005 with majors in medical information management and information systems. After graduation she worked in various roles including Network and Data Manager, Call Center Manager, IT Engineer and Customer Relationship Manager. Previously she was the project assistnat to the China Rural Health Initiative (CHRI).

Norbert Berend is Head of Respiratory Research at the George Institute for Global Health and a member of the physiology group at the Woolcock Institute of Medical Research of which he was the Director from 2000 to 2012. He holds the academic title of Professor, Faculty of Medicine, UNSW Sydney; Professor Emeritus at the University of Sydney; and is a Visiting or Honorary Professor at three Chinese Universities.

He is a past President of the Thoracic Society of Australia and New Zealand and the Asian Pacific Society of Respirology. He has also held positions with the American Thoracic Society and European Respiratory Society. Norbert’s research interests include the pathophysiology of asthma and COPD and clinical intervention studies to improve the outcome of airways disease.

Norbert is a recipient of the TSANZ Medal, the APSR Medal and has received an Award of Merit from the European Respiratory Society. In 2003 Norbert was made a Member of the Order of Australia for services to respiratory medicine.